BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10950832)

  • 1. Inhibition of lipolysis causes suppression of endogenous glucose production independent of changes in insulin.
    Mittelman SD; Bergman RN
    Am J Physiol Endocrinol Metab; 2000 Sep; 279(3):E630-7. PubMed ID: 10950832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs.
    Rebrin K; Steil GM; Mittelman SD; Bergman RN
    J Clin Invest; 1996 Aug; 98(3):741-9. PubMed ID: 8698866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of free fatty acids on glucose uptake and utilization in healthy women.
    Homko CJ; Cheung P; Boden G
    Diabetes; 2003 Feb; 52(2):487-91. PubMed ID: 12540625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of plasma free fatty acids on glucose production in the conscious dog.
    Wolfe RR; Shaw JH
    Am J Physiol; 1984 Feb; 246(2 Pt 1):E181-6. PubMed ID: 6141738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo.
    Park E; Wong V; Guan X; Oprescu AI; Giacca A
    J Endocrinol; 2007 Nov; 195(2):323-31. PubMed ID: 17951543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response effect of elevated plasma free fatty acid on insulin signaling.
    Belfort R; Mandarino L; Kashyap S; Wirfel K; Pratipanawatr T; Berria R; Defronzo RA; Cusi K
    Diabetes; 2005 Jun; 54(6):1640-8. PubMed ID: 15919784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia.
    Mittelman SD; Fu YY; Rebrin K; Steil G; Bergman RN
    J Clin Invest; 1997 Dec; 100(12):3121-30. PubMed ID: 9399959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites.
    Lam TK; van de Werve G; Giacca A
    Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E281-90. PubMed ID: 12531742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of insulin resistance after insulin-induced hypoglycemia in humans: the role of lipolysis.
    Lucidi P; Rossetti P; Porcellati F; Pampanelli S; Candeloro P; Andreoli AM; Perriello G; Bolli GB; Fanelli CG
    Diabetes; 2010 Jun; 59(6):1349-57. PubMed ID: 20299466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of IGF-I on FFA and glucose metabolism in control and type 2 diabetic subjects.
    Pratipanawatr T; Pratipanawatr W; Rosen C; Berria R; Bajaj M; Cusi K; Mandarino L; Kashyap S; Belfort R; DeFronzo RA
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1360-8. PubMed ID: 12006367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes.
    Boden G; Chen X
    J Clin Invest; 1995 Sep; 96(3):1261-8. PubMed ID: 7657800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo.
    Pereira S; Park E; Moore J; Faubert B; Breen DM; Oprescu AI; Nahle A; Kwan D; Giacca A; Tsiani E
    Appl Physiol Nutr Metab; 2015 Nov; 40(11):1129-36. PubMed ID: 26455923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of fatty acids on glucose production and utilization in man.
    Ferrannini E; Barrett EJ; Bevilacqua S; DeFronzo RA
    J Clin Invest; 1983 Nov; 72(5):1737-47. PubMed ID: 6138367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production.
    Carey PE; Gerrard J; Cline GW; Dalla Man C; English PT; Firbank MJ; Cobelli C; Taylor R
    Am J Physiol Endocrinol Metab; 2005 Dec; 289(6):E941-7. PubMed ID: 15998660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free fatty acids and insulin resistance during pregnancy.
    Sivan E; Homko CJ; Whittaker PG; Reece EA; Chen X; Boden G
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2338-42. PubMed ID: 9661605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis.
    Boden G; Cheung P; Stein TP; Kresge K; Mozzoli M
    Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E12-9. PubMed ID: 12067837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nicotinic acid on fatty acid kinetics, fuel selection, and pathways of glucose production in women.
    Wang W; Basinger A; Neese RA; Christiansen M; Hellerstein MK
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E50-9. PubMed ID: 10893322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of complete suppression of endogenous glucose production by euglycaemic hyperinsulinaemia in normal humans.
    Neely RD; Harper R; Rooney DP; Ennis CN; Bell PM; Trimble ER
    Eur J Clin Invest; 1995 Jun; 25(6):447-53. PubMed ID: 7656925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
    Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct and indirect effects of insulin in suppressing glucose production in depancreatized dogs: role of glucagon.
    Giacca A; Fisher SJ; McCall RH; Shi ZQ; Vranic M
    Endocrinology; 1997 Mar; 138(3):999-1007. PubMed ID: 9048601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.